JnJ Imaavy gets USFDA okay for generalized myasthenia gravis Ruchika Sharma1 May 2025 1:15 PM ISTSpring House: Johnson & Johnson has received approval from the U.S. Food and Drug Administration (FDA) for IMAAVY (nipocalimab-aahu), a human...
JnJ closes Intra-Cellular Therapies acquisition Ruchika Sharma3 April 2025 10:30 AM ISTNew Brunswick: Johnson & Johnson has announced it has completed its acquisition of Intra-Cellular Therapies, Inc. Intra-Cellular Therapies is...
JnJ Nipocalimab gets USFDA Fast Track designation for Sjogren's disease Ruchika Sharma19 March 2025 1:30 PM ISTSpring House: Johnson & Johnson has received Fast Track designation (FTD) from the U.S. Food and Drug Administration (FDA) for...
JnJ MedTech gets clearance for MONARCH QUEST for enhanced Robotic-Assisted Bronchoscopy Ruchika Sharma14 March 2025 10:00 AM ISTSanta Clara: Johnson & Johnson MedTech has announced U.S. 510(k) regulatory clearance for MONARCH QUEST, the latest advancement in MONARCH...
JnJ to discontinue Phase 3 VENTURA development program evaluating aticaprant for major depressive disorder Ruchika Sharma7 March 2025 1:30 PM ISTTitusville: Johnson & Johnson has announced the decision to discontinue the Phase 3 VENTURA development program evaluating aticaprant as an...
JnJ names Darren Snellgrove as Vice President, Investor Relations Ruchika Sharma5 March 2025 12:51 PM ISTNew Brunswick: Johnson & Johnson has announced the appointment of Darren Snellgrove to Vice President of Investor Relations. Jessica Moore,...
JnJ to resume US VARIPULSE cases Ruchika Sharma20 Feb 2025 9:30 AM ISTNew Brunswick: Johnson & Johnson will resume the limited market release of VARIPULSE in the United States after a comprehensive...
Johnson & Johnson MedTech launches CEREGLIDE 92 Catheter System for Acute ischemic stroke Ruchika Sharma13 Feb 2025 4:54 PM ISTIrvine: Johnson & Johnson MedTech, an emerging leader in neurovascular care, has announced the launch of the CEREGLIDE 92 Catheter System, a...
JnJ Spravato gets USFDA nod as monotherapy for adults with treatment-resistant depression Ruchika Sharma22 Jan 2025 11:35 AM ISTTitusville: Johnson & Johnson has announced the U.S. Food and Drug Administration (FDA) approval of a supplemental New Drug Application...
JnJ initiates submission of New Drug Application with USFDA for TAR-200 for BCG-unresponsive high-risk non-muscle-invasive bladder cancer Ruchika Sharma16 Jan 2025 12:30 PM ISTRaritan: Johnson & Johnson has announced it has initiated the submission of an original New Drug Application with the U.S. Food and Drug...
Controversy erupts over sugary drink display at ORSL stall during pedicon conference Yakshi Chugh15 Jan 2025 6:15 PM ISTThe recently held annual conference of the Indian Academy of Pediatrics (IAP) led to a controversy after the event included an exhibition stall for...
JnJ to acquire Intra-Cellular Therapies for USD 14.6 billion Ruchika Sharma15 Jan 2025 11:30 AM ISTNew Brunswick: Johnson & Johnson and Intra-Cellular Therapies, Inc. have announced that they have entered into a definitive agreement under...
